Terms & Conditions

We have Recently updated our Terms and Conditions. Please read and accept the terms and conditions in order to access the site

Welcome to our website. Esperity Health is a product of Esperity bv. If you continue to browse and use this website, you are agreeing to comply with and be bound by the following terms and conditions of use. If you disagree with any part of these terms and conditions, please do not use our website.   The brand name ‘Esperity bv’, ‘us’ or ‘we’ refers to the owner of the website whose registered office is Clos Chapelle-aux-Champs 30, 1200 Brussels. Our company registration number is 0848.466.027. The term ‘you’ refers to the user or viewer of our website.   The use of this website is subject to the following terms of use:
  • The content of the pages of this website is for your general information and use only. It is subject to change without notice.
  • This website uses cookies to monitor browsing preferences. If you do allow cookies to be used, the following personal information may be stored by us for use by third parties: email and/or telephone number sent via the contact form.
  • Neither we nor any third parties provide any warranty or guarantee as to the accuracy, timeliness, performance, completeness or suitability of the information and materials found or offered on this website for any particular purpose. You acknowledge that such information and materials may contain inaccuracies or errors and we expressly exclude liability for any such inaccuracies or errors to the fullest extent permitted by law.
  • Your use of any information or materials on this website is entirely at your own risk, for which we shall not be liable. It shall be your own responsibility to ensure that any products, services or information available through this website meet your specific requirements.
  • This website contains material which is owned by or licensed to us. This material includes, but is not limited to, the design, layout, look, appearance and graphics. Reproduction is prohibited other than in accordance with the copyright notice, which forms part of these terms and conditions.
  • All trademarks reproduced in this website, which are not the property of, or licensed to the operator, are acknowledged on the website.
  • Unauthorised use of this website may give rise to a claim for damages and/or be a criminal offence.
  • From time to time, this website may also include links to other websites. These links are provided for your convenience to provide further information. They do not signify that we endorse the website(s). We have no responsibility for the content of the linked website(s).
  • Your use of this website and any dispute arising out of such use of the website is subject to the laws of Belgium. Last update of these terms: 1 july 2022

Current Version: 1

Privacy Policy

We have Recently updated our Privacy Policy. Please read and accept the Privacy Policy in order to access the site

Current Version: 1

Phase 1 Clinical Trials with Patients

When people think of clinical trials, Phase 1 is often seen as the most experimental—and the riskiest. Traditionally, it involves healthy volunteers, aiming to determine if a new drug is safe. However, in certain life-threatening conditions, especially oncology, patients themselves are included right from the beginning.

This is not a loophole—it’s a regulated, ethical, and often life-saving decision, fully aligned with the European Regulation (EU) No. 536/2014. Trusted platforms like clinicaltrial.be ensure transparency and legitimacy, showing real, authorized studies in Belgium.

What is a clinical trial and how is it structured?

A clinical trial is a carefully designed study that tests how well new medical interventions—like drugs or therapies—work and whether they’re safe. Trials typically move through four phases:

When patients participate in Phase 1 trials

In most cases, Phase 1 trials enroll healthy adults. However, exceptions exist—and are especially justified when:

Cancer is the most cited example. Here, Phase 1 trials often double as treatment opportunities, providing hope where conventional therapy has failed.

What the European law says (EU Regulation No. 536/2014)

This regulation ensures that all clinical trials in the European Union are:

This law places special emphasis on the protection of vulnerable populations, including patients who join early-stage trials. It requires:

Why clinicaltrial.be is your best ally

clinicaltrial.be is Belgium’s official database of registered clinical studies. It allows:

It complements other databases like EudraCT and ClinicalTrials.gov, but with local language and direct Belgian compliance checks.

Real-world examples in Belgium

Current Phase 1 studies listed on clinicaltrial.be include:

These studies are conducted in top-tier facilities such as UZ Leuven, Jules Bordet Institute, and Cliniques Universitaires Saint-Luc.

Ethical and medical oversight

Including patients in Phase 1 trials isn’t a shortcut—it’s a carefully controlled process that involves:

Moreover, only certified research centers with intensive care units and specialized staff can host such trials.

Benefits: More than just access to treatment

Patients who enter Phase 1 trials may experience:

For many, this is not just hope—it’s purpose.

FAQs

Do all Phase 1 trials include patients?
No. Only specific conditions (like cancer or rare diseases) warrant patient inclusion in Phase 1.

Are these trials ethical?
Yes. They require ethics committee approval, informed consent, and follow strict EU laws.

How can I find a Phase 1 trial in Belgium?
Use clinicaltrial.be to find ongoing and verified studies.

Is it dangerous to participate in Phase 1?
There are risks, but strict safety measures and constant monitoring significantly reduce them.

Can I participate if I’m not a Belgian citizen?
Yes, if you meet the medical eligibility and are present in Belgium for the trial period.

Will I be paid to participate?
In most cases, patients are not financially compensated, but may receive expense reimbursements.

Conclusion

Phase 1 clinical trials with patients reflect how science, ethics, and hope can work hand-in-hand. By participating, patients not only access potentially life-saving therapies, but also contribute to the development of future treatments for others. With EU-level protections and trusted platforms like clinicaltrial.be, the path to innovation remains safe, transparent, and grounded in trust.


Internal (example pages on your site):

External (trusted sources):

Leave a Reply

Your email address will not be published. Required fields are marked *